Kenvue Inc. (FRA:J4D)

Market Cap	35.60B
Revenue (ttm)	14.13B
Net Income (ttm)	974.90M
Shares Out	n/a
EPS (ttm)	0.51
PE Ratio	36.52
Forward PE	18.67
Dividend	0.76 (4.27%)
Ex-Dividend Date	May 14, 2025

Volume	n/a
Average Volume	4
Open	18.08
Previous Close	17.94
Day's Range	17.83 - 18.10
52-Week Range	16.31 - 23.25
Beta	n/a
RSI	26.92
Earnings Date	Aug 7, 2025

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2022
• Employees: 22,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: J4D

Financial Performance

In 2024, Kenvue's revenue was $15.46 billion, an increase of 0.07% compared to the previous year's $15.44 billion. Earnings were $1.03 billion, a decrease of -38.10%.

Financial numbers in USD